In addition, we found that higher levels of pathway activity—indicated by the expression of phosphorylated (p)-mTOR, p-AKT, and p-S6K1—were associated with lower tumor grade, smaller tumors, earlier stage at diagnosis, and luminal subtype. The gene discussed is MTOR; the disease is neoplasm.